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Abstract
Purpose The role of diet in bladder carcinogenesis has yet to be established. To date most studies have investigated dietary 
components individually, rather than as dietary patterns, which may provide stronger evidence for any influence of diet on 
bladder carcinogenesis. The Mediterranean diet has been associated with many health benefits, but few studies have inves-
tigated its association with bladder cancer risk.
Methods We investigated the potential association between the Mediterranean diet score (MDS) and risk of developing 
bladder cancer by pooling 13 prospective cohort studies included in the BLadder cancer Epidemiology and Nutritional 
Determinants (BLEND) study and applying a Cox regression analysis.
Results Dietary data from 646,222 study participants, including 3639 incident bladder cancer cases, were analysed. We 
observed an inverse association between Mediterranean diet and bladder cancer risk  (HRhigh 0.85 [95% CI 0.77, 0.93]). 
When stratifying the results on non-muscle-invasive or muscle-invasive disease or sex the association remained similar and 
the HR estimate was consistently below 1.00 both for medium and high adherence to the Mediterranean diet. A consistent 
association was observed when disregarding fat or alcohol intake.
Conclusion We found evidence that adherence to the Mediterranean diet was associated with reduced risk of developing 
bladder cancer, suggesting a positive effect of the diet as a whole and not just one component.
Keywords Mediterranean diet · Bladder cancer · Bladder cancer risk · Epidemiology
Abbreviations
BLEND  BLadder cancer Epidemiology and Nutri-
tional Determinants
95% CI  95% confidence interval
EPIC  European Prospective Investigation into 
Cancer and Nutrition
FFQ  Food Frequency Questionnaire
HR  Hazard ratio
MCCS  Melbourne Collaborative Cohort Study
MIBC  Muscle-invasive bladder cancer
NMIBC  Non-muscle-invasive bladder cancer
OR  Odds ratio
TNM stage  Tumour nodes metastasis stage
Introduction
Bladder cancer is the sixth leading cancer in the USA, with 
an estimated 81,190 new cases and 17,240 deaths in 2018. 
Over 75% of all patients are still alive after 5 years [1]. 
Moreover, bladder cancer has high recurrence and is the 
most expensive malignancy to treat, accounting for > 3% 
of all cancer-related medical payments in the USA [2]. At 
present the better established risk factors associated with 
developing bladder cancer include smoking, age, male sex, 
occupation, and to a lesser extent obesity and physical inac-
tivity [3–5]. Since most of the metabolites of ingested food 
come into direct contact with the bladder mucosa, diet might 
also play a role in the development of bladder cancer [6].
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Previous studies of diet-related bladder cancer risk factors 
have tended to focus on single food items [7, 8]. For exam-
ple, the Multiethnic Cohort (MEC) study, which included 
a total of 185,885 participants and 1137 incident bladder 
cancer cases, reported a hazard ratio (HR) of 0.40 (95% CI 
0.23–0.69) comparing highest and lowest quartiles of veg-
etable intake [9]. Also, the Los Angeles Bladder Cancer 
(case–control) Study involving 3246 participants, including 
1660 cases, reported a positive association between intake 
of red meat (salami, pastrami and beef) and bladder cancer 
risk (comparing highest and lowest quintile: OR 1.33, 95% 
CI 1.02–1.74) [10]. Emerging evidence suggests that total 
dietary patterns may provide stronger evidence for diet–dis-
ease associations than individual dietary items [11].
The Mediterranean diet has been reported to be effec-
tive for preventing non-communicable diseases [12–15] 
and reducing overall mortality and the incidence of several 
cancers [16, 17]. It is generally characterized by a high con-
sumption of fruits, vegetables, legumes and cereals, mod-
erate-to-high consumption of fish, moderate consumption 
of alcohol (mostly wine), low-to-moderate consumption of 
milk and dairy products, and low consumption of meat and 
meat products [18]. The diet distinguishes itself from other 
dietary recommendations and indices such as the Healthy 
Eating Index [19], the World Cancer Research Fund and 
American Institute for Cancer Research (WCRF/AICR) diet 
recommendations [20] and the Diet Inflammatory Index 
[21], by its higher levels of dietary fat, mainly monounsatu-
rated fat from olive oil, and higher alcohol consumption, 
mainly from wine, although alcohol is a risk factor for sev-
eral cancers [22–26].
To date, few studies [27, 28] have investigated the asso-
ciation between Mediterranean diet and bladder cancer. The 
European Prospective Investigation into Cancer and Nutri-
tion (EPIC) cohort study, including 477,312 participants (of 
which 1425 were incident cases), found an inverse but non-
significant association comparing a high with a low Medi-
terranean diet score (MDS) and urothelial cell carcinoma 
(UCC) overall (HR 0.84 [95% CI 0.69, 1.03]), and for risk of 
aggressive (HR 0.88 [95% CI 0.61, 1.28]) and non-aggres-
sive disease (HR 0.78 [95% CI 0.54, 1.14]). The association 
was statistically significant for current smokers (HR 0.66 
[95% CI 0.47, 0.93]) [27]. Researchers from the Melbourne 
Collaborative Cohort Study (MCCS), which included 37,442 
participants at time of recruitment (379 incident cases), 
reported an inverse association for both sexes between the 
MDS and invasive UCC (HR 0.86 [95% CI 0.74, 1.00]) [28].
Our primary aim was to build on the results of the EPIC 
cohort study and the MCCS, and to investigate prospectively 
the potential association between Mediterranean diet and 
the risk of developing bladder cancer, by aggregating data 
from 13 cohort studies in a pooled analysis using a meta-
analysis approach. Our secondary aims were to examine 
heterogeneity in any association by sex and disease sub-type 
(non-muscle-invasive and muscle-invasive bladder cancer).
Materials and methods
Study population
Data were analysed from the Bladder cancer Epidemiology 
and Nutritional Determinants (BLEND) study. BLEND is a 
large international nutritional consortium, which included 
16 cohort studies conducted in several countries. Thirteen 
of the 16 cohort studies had sufficient information on food 
items to be eligible for inclusion in our study on adherence 
to the Mediterranean diet and the risk of developing bladder 
cancer. Studies originated from centres in Denmark [29], 
France [30], Germany [31], Greece [32], Italy [32, 33], The 
Netherlands [34], Norway [35], Spain [32], Sweden [36–38] 
United Kingdom [39, 40], the USA [41], and Australia [42, 
43].
Data collection and coding
Details on the methodology of the BLEND consortium 
have been described elsewhere [44]. Briefly, the primary 
data from all included studies were incorporated into one 
dataset. All data provided were checked and converted from 
daily, monthly, or yearly food intake to weekly intake, and 
intakes by portion were also converted to intake by grams. 
Data on bladder cancer diagnosis were mainly ascertained 
by self-reported questionnaires. Dietary data, collected using 
food frequency questionnaires in all studies, were recoded 
using the Eurocode 2 food coding system [45]. In addition 
to information on dietary intake, the BLEND data also 
included study characteristics (design, method of dietary 
assessment, recall time of dietary intake and geographical 
region), participant demographics (age, sex, and ethnicity), 
bladder cancer pathology (non-muscle-invasive and muscle-
invasive disease), and smoking status (current/former/never) 
all measured at baseline.
Mediterranean diet score
To measure the degree of adherence to the Mediterranean 
diet, we used a nine-point scale that was constructed by 
Trichopoulou et al. [46]. Nine food items were included, 
namely, consumption of (1) cereals, (2) fruits and nuts, (3) 
vegetables, (4) legumes, (5) fish, (6) meat, (7) dairy prod-
ucts, (8) fats, and (9) alcohol/ethanol. For each component, 
a value of 0 or 1 was assigned using its sex-specific median 
for each study as a cutoff value. For the presumed beneficial 
components (vegetables, legumes, fruits and nuts, cereals, 
and fish), a value of 0 was assigned to those consuming less 
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than the median cutoff, and a value of 1 was assigned to 
those consuming as much as the median cutoff or more. For 
the presumed detrimental components (meat and dairy prod-
ucts), a value of 1 was assigned to those consuming less than 
the median cutoff, and a value of 0 was assigned to those 
consuming as much as the median cutoff or more. For alco-
hol, a value of 1 was assigned to men consuming between 
70 and 350 g per week and to women consuming between 
35 and 175 g per week. We assumed that one portion of 
alcohol of any type contained a standard amount of 10 g of 
ethanol. For fat intake, we calculated the ratio of fats from 
plant sources to total fat and assigned a value of 0 to those 
consuming less than the median cutoff, and a value of 1 to 
those consuming as much as the median cutoff or more. We 
used the ratio of plant-to-total fat because we hypothesized 
that the effect of dietary fat may depend on its source and not 
solely on the quantity consumed. For example, monounsatu-
rated fat is present in both olive oil and animal products, and 
by just summing up the total amount of monounsaturated fat 
consumed it may not take into account the potentially differ-
ent biological responses related to dietary source.
The MDS ranged from 0 (minimal adherence) to 9 (max-
imal adherence). Scores between 0 and 3 were classified 
as “low adherence”, scores of 4 and 5 were classified as 
“medium adherence”, and scores of 6 or higher were classi-
fied as “high adherence”.
Statistical analysis
Cox proportional hazard models using age at recruitment as 
the starting point on the time scale were used to calculate 
HRs and 95% confidence intervals (95% CI) for developing 
bladder cancer, comparing medium and high adherence with 
low adherence. The MDS was also analysed as a continuous 
variable (0–9). The proportional hazards assumption was 
examined through Schoenfeld residuals [47]. When consid-
ering all included participants, the assumption of propor-
tional hazards was violated and therefore we compared the 
association between MDS score and risk of bladder cancer 
in all subjects younger than 70 years and in those older than 
70 years to assess to what degree the HR changed over time. 
The Cox regression models were all adjusted for total energy 
intake in kilocalories (by applying a restricted cubic spline), 
sex and smoking status (never, former or current smoker). 
Furthermore, survival time was estimated by subtracting age 
at exit by age at entry in the cohort as T0, thereby correcting 
for age in the analysis and also the study sample from which 
the cases originated was corrected for by introducing study 
ID as a random effect. Analyses were stratified on sex and 
disease sub-type (non-muscle-invasive or muscle-invasive 
disease). To test for residual confounding by smoking, the 
association between MDS score and risk of bladder cancer 
was also investigated while stratifying for smoking status 
(ever/never).
Additionally, unstratified analyses were repeated to deter-
mine the effect of both alcohol and fats as two distinctive 
features of Mediterranean diet, with alterations to the esti-
mation of the MDS in an exploratory analysis. To test the 
effect of alcohol on the MDS, we excluded the alcohol com-
ponent from the diet score. For fats, we repeated the analy-
sis by excluding fats from the diet score altogether and by 
replacing the lipid ratio (fats from plant sources divided by 
total fats) with only olive oil intake. All statistical analyses 
were performed using Stata/SE 14.2 [48].
Results
Dietary data from 646,222 study participants, including 
3639 incident cases and 642,583 non-cases were analysed. 
Disease sub-type was known for 2425 cases, of which 
945 (39%) were muscle-invasive bladder cancer (MIBC) 
and 1480 (61%) were non-muscle-invasive bladder cancer 
(NMIBC). Compared with non-cases, bladder cancer cases 
were more likely to be male (74%) and to be current or for-
mer smokers (79%). Of all cases, 22% originated from Scan-
dinavian countries, 12% from Mediterranean regions, and 
42% from other countries in Western Europe. The remaining 
24% of the cases were living in the USA (10%) or Australia 
(14%); the Australian study (MCCS) oversampled people 
born in Greece or Italy [42, 43] (Table 1).
The overall HR estimates for bladder cancer associated 
with MDS, after adjustment for total energy intake, smoking 
status, and sex, are presented in Table 2. A total of 6,577,179 
person years, including 3581 cases, were analysed. Overall, 
high adherence to the Mediterranean diet was associated 
with a decrease in bladder cancer risk compared with low 
adherence  (HRhigh 0.85 [95% CI 0.77, 0.93]). A decreased 
bladder cancer risk was also found for medium compared 
with low adherence to the Mediterranean diet  (HRmedium 0.91 
[95% CI 0.85, 0.99]). In addition, an inverse linear associa-
tion was found between a one-unit increase in adherence 
to the Mediterranean diet and risk of developing bladder 
cancer  (HRcontinuous 0.96 [95% CI 0.94, 0.98]). Although the 
proportional hazards assumption was violated, the results 
were similar when considering only those younger than 
70 years at entry in the study  (HRhigh 0.80, [95% CI 0.72, 
0.89],  HRmedium 0.90, [95% CI 0.83, 0.98]) separately from 
those older than 70 years at entry in the study  (HRhigh 0.86, 
[95% CI 0.57, 1.29],  HRmedium 0.82, [95% CI 0.60, 1.14]), 
indicating that the presented HRs in Tables 2 and 3 were 
probably not heavily influenced by this violation. Further-
more, residual confounding by smoking seemed minimal 
as the results in never smokers  (HRhigh 0.84, [95% CI 0.68, 
1.04],  HRmedium 0.84, [95% CI 0.71, 0.99]) were similar to 
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Table 1  Characteristics of the 13 eligible studies according to subject status, sex, age, TNM stage, and smoking status
Study Denmark 
(EPIC)
France (EPIC) Germany 
(EPIC)
Greece (EPIC) Italy (EPIC) The Nether-
lands (EPIC)
Norway 
(EPIC)
No. %a No. %a No %a No. %a No. %a No. %a No. %a
Subject status
 Total 56,005 100 64,866 100 49,457 100 25,268 100 45,204 100 37,102 100 33,856 100
  Cases 411 < 1 31 < 1 218 < 1 50 < 1 192 < 1 119 < 1 24 < 1
  Non-cases 55,594 > 99 64,835 > 99 49,239 > 99 25,218 > 99 45,012 > 99 36,983 > 99 33,832 > 99
 Sex
  Men 26,764 48 0 0 21,551 44 10,438 41 14,084 31 9801 26 0 0
  Women 29,241 52 64,866 100 27,906 56 14,830 59 31,120 69 27,301 74 33,856 100
 Age
  < 50 0 0 27,158 42 23,661 48 10,715 42 21,565 48 16,161 43 21,301 63
  50–59 40,996 73 26,392 41 16,978 34 5542 22 17,791 39 14,720 40 12,555 37
  60–69 15,009 27 11,286 17 8817 18 6455 26 5647 13 6217 17 0 0
  ≥ 70 0 0 30 < 1 1 < 1 2556 10 201 < 1 4 < 1 0 0
 TNM stage
  Invasive 44 24 5 12 40 26 N/A N/A 20 20 23 20 N/A N/A
  Non-invasive 138 76 22 78 114 74 N/A N/A 104 80 93 80 N/A N/A
 Smoking status
  Never smoker 19,624 35 45,797 71 22,658 46 14,060 56 20,540 45 14,171 38 12,057 36
  Former smoker 17,070 31 13,121 20 16,386 33 4232 17 12,096 27 11,572 31 10,438 31
  Current smoker 19,311 34 5948 9 10,413 21 6976 27 12,568 28 11,359 31 11,361 33
 MDS
  0–3 12,595 22 30,882 48 19,758 40 6895 27 13,935 31 16,255 44 12,147 36
  4–5 25,549 46 28,380 44 22,919 46 12,073 48 23,186 51 16,484 44 15,600 46
  6–9 17,861 32 5604 8 6780 14 6300 25 8083 18 4363 12 6109 18
Study Spain (EPIC) Sweden (EPIC) United Kingdom 
(EPIC)
USA (VITAL) Netherlands (NLCS) Australia 
(MCCS)b
No. %a No. % No. %a No. %a No. %a No. %a
Subject status
 Total 40,782 100 49,328 100 75,035 100 76,433 100 5,632 100 38,263 100
  Cases 154 < 1 303 < 1 250 < 1 378 < 1 940 17 520 1
  Non-
cases
40,628 > 99 49,025 > 99 74,785 > 99 76,055 > 99 4692 83 37,743 99
 Sex
  Men 15,439 38 22,546 46 22,476 30 36,792 52 3052 54 15,798 41
  Women 25,343 62 26,782 54 52,559 70 40,089 48 2580 46 22,465 59
 Age
  < 50 22,824 56 19,136 39 39,461 52 0 0 0 0 12,047 32
  50–59 12,936 32 16,794 34 17,049 23 35,262 46 2058 37 12,560 33
  60–69 5022 12 11,150 23 12,553 17 26,685 35 3534 63 13,108 34
  ≥ 70 0 0 2248 4 5972 8 14,934 19 40 < 1 548 1
 TNM stage
  Invasive 7 14 N/A N/A 6 86 121 35 443 52 232 45
  Non-
invasive
50 86 N/A N/A 1 14 229 65 409 48 288 55
 Smoking status
  Never 
smoker
22,599 55 24,205 49 41,948 56 36,478 47 1848 33 22,057 58
  Former 
smoker
7207 18 13,410 27 23,924 32 33,931 44 2018 36 11,848 31
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those in ever smokers  (HRhigh 0.80, [95% CI 0.71, 0.89], 
 HRmedium 0.90, [95% CI 0.83, 0.98]).
Results remained consistently below 1.00 for non-
muscle-invasive  (HRhigh 0.86 [95% CI 0.74, 0.99]) and 
muscle-invasive  (HRhigh 0.89 [95% CI 0.74, 1.07]) patients 
after stratification on disease sub-type (Table 2).
Results for men  (HRhigh 0.86 [95% CI 0.77–0.96], 
 HRmedium 0.89 [95% CI 0.82, 0.97]) and women  (HRhigh 
Table 1  (continued)
Study Spain (EPIC) Sweden (EPIC) United Kingdom 
(EPIC)
USA (VITAL) Netherlands (NLCS) Australia 
(MCCS)b
No. %a No. % No. %a No. %a No. %a No. %a
  Current 
smoker
10,976 27 11,713 24 9163 12 6490 9 1766 31 4358 11
MDS
  0–3 20,067 49 13,466 27 24,162 32 29,434 39 2181 39 22,326 59
  4–5 17,231 42 25,798 52 29,122 39 29,194 39 2409 43 10,411 27
  6–9 3484 9 10,064 21 21,751 29 15,921 22 1042 18 5314 14
EPIC European prospective investigation into cancer and nutrition, NLCS Netherlands Cohort Study, VITAL VITamins And Lifestyle Study, 
MCCS Melbourne Collaborative Cohort Study, TNM stage tumour nodes metastasis stage, MIBC muscle-invasive bladder cancer, NMIBC non-
muscle-invasive bladder cancer
a The sum does not add up to the total, because of missing values
b Recruitment of the MCCS is still ongoing, therefore the presented number of participants differ from the 2016- and 2017-published numbers by 
Dugue et al.
Table 2  Pooled HR and 95% CI for the association between adherence to the Mediterranean diet and risk of developing bladder cancer for all 
bladder cancer, by sex, and by disease sub-type
a All results are from multivariate model adjusted for total energy intake, smoking status and sex & age at study inclusion and study sample 
through setting of survival time
b Total number of cases in adherence category may change by sex, because adherence is calculated separately in each stratum
c Number of cases do not add up, because of missing values on stage at diagnosis
d Total number of cases in analysis (3.581) lower than Table 1 (3.590) because of missing values in energy intake and/or MDS score
Diet  scorea Both sexes Male Female
Cases/person-
timeb
Pooled HR 95% CI Cases/person-
timea
Pooled HR 95% CI Cases/person-
timea
Pooled HR 95% CI
All bladder  cancerc
 Low (0–3) 1483/2,460,613 1.00 Reference 1082/756,521 1.00 Reference 399/1,703,192 1.00 Reference
 Medium (4–5) 1479/2,868,685 0.91 0.85–0.99 1113/951,445 0.89 0.82–0.97 340/1,920,564 0.84 0.73–0.98
 High (6–9) 619/1,247,881 0.85 0.77–0.93 498/462,294 0.86 0.77–0.96 149/783,160 0.90 0.74–1.10
 MDS continu-
ous
3581d/6,577,179 0.96 0.94–0.98 2693/2,170,260 0.95 0.93–0.98 888/4,406,918 0.96 0.92–1.00
Non-muscle-invasive
 Low (0–3) 643/2,156,174 1.00 Reference 484/652,250 1.00 Reference 176/1,449,731 1.00 Reference
 Medium (4–5) 620/2,256,426 0.93 0.83–1.04 446/748,953 0.82 0.72–0.94 138/1,510,539 0.86 0.68–1.09
 High (6–9) 251/933,699 0.86 0.74–0.99 212/370,334 0.87 0.74–1.03 58/614,493 0.94 0.69–1.29
 MDS continu-
ous
1514/5,346,298 0.96 0.94–0.99 1142/1,771,536 0.96 0.92–0.99 372/3,574,763 0.97 0.92–1.04
Muscle-invasive
 Low (0–3) 408/1,291,420 1.00 Reference 326/475,555 1.00 Reference 87/796,549 1.00 Reference
 Medium (4–5) 355/1,427,419 0.88 0.76–1.02 279/570,121 0.80 0.68–0.95 73/850,470 0.99 0.70–1.38
 High (6–9) 167/625,505 0.89 0.74–1.07 132/290,429 0.85 0.69–1.05 33/316,218 1.05 0.68–1.60
 MDS continu-
ous
930/3,344,345 0.94 0.90–0.97 737/1,336,106 0.94 0.90–0.98 193/2,008,238 0.95 0.88–1.04
 European Journal of Nutrition
1 3
0.90 [95% CI 0.74–1.10],  HRmedium 0.84 [95% CI 0.73, 
0.98]) were comparable and in line with the overall esti-
mates. Although total person-time was higher for women, 
the total number of cases was much higher for men 
(Table 2).When stratified on both disease sub-type and 
sex, HRs were consistently below 1.00, except for high 
compared with low adherence to the Mediterranean diet 
and risk of muscle-invasive disease for women  (HRhigh 
1.05 [95% CI 0.68, 1.60]) (Table 2).
In the exploratory analysis, we obtained similar results 
after excluding either fats  (HRhigh 0.88 [95% CI 0.78, 0.99], 
 HRmedium 0.92 [95% CI 0.85, 0.99]) or alcohol  (HRhigh 0.93 
[95% CI 0.83, 1.04],  HRmedium 0.93 [95% CI 0.86, 1.00]) 
from the diet score. Also, consistent results were found in 
the relation between adherence to the Mediterranean diet 
and bladder cancer risk when we replaced the lipid ratio 
(fats from plant sources divided by total fats) with olive oil 
intake only  (HRhigh 0.82 [95% CI 0.74, 0.90],  HRmedium 0.91 
[95% CI 0.84, 0.98]).
Discussion
Main findings
We investigated the association between adherence to the 
Mediterranean diet and bladder cancer risk and observed an 
overall inverse association between a high adherence to the 
Mediterranean diet and the risk of developing bladder can-
cer. Analyses stratified by sex and disease sub-type showed 
similar results, indicating that the association is unlikely to 
be confounded by factors that might differ between these 
subgroups.
Previously published results from studies that have inves-
tigated the association between adherence to the Mediter-
ranean diet and the risk of developing bladder cancer are in 
line with our findings. Although not statistically significant, 
Buckland et al. [27] reported inverse associations between 
adherence to the Mediterranean diet and risk of overall, 
aggressive or non-aggressive bladder cancer for men and 
women. In contrast to our association between Mediterra-
nean dietary adherence and non-muscle-invasive disease, 
Dugué et al. [28], based on the MCCS, found a weak inverse 
association between adherence to the Mediterranean diet and 
urothelial cell carcinoma only. It is worth mentioning that 
these two studies [27, 28] used different dietary fat assess-
ment measures for the Mediterranean diet. Buckland et al. 
also used a different grading score for determining dietary 
adherence.
Despite the limited evidence for a role of the Mediterra-
nean diet in the development of bladder cancer overall, sev-
eral studies have focused on some key elements of this die-
tary pattern and found some beneficial effects. For example, Ta
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it has been shown that the consumption of vegetables and 
fruits is inversely associated with the risk of bladder cancer 
[9, 49]. This finding is not unexpected, since both vegetables 
and fruits contain large quantities of polyphenols, carote-
noids, and vitamins C and E, which have antioxidant func-
tions, allowing them to prevent DNA damage by neutralizing 
reactive oxygen species [50, 51]. Conversely, a positive asso-
ciation with the risk of developing bladder cancer has been 
reported for high consumption of animal products, such as 
red and processed meats and animal proteins [52–54]. Dur-
ing high-temperature cooking of meat, specific substances 
which are known to be involved in bladder cancer carcino-
genesis are formed [55]. In addition, red meat is rich in iron, 
which is associated with increased formation of N-nitroso 
compounds (NOCs). These compounds have been suggested 
to induce tumours in the bladder [56].
While reportedly lower in saturated and animal fats, the 
Mediterranean diet is associated with a higher intake of 
dietary fat (approximately 35% of total energy intake) usu-
ally from monounsaturated dietary fat. Another important 
element of the Mediterranean diet that has been studied as a 
single food item in the relation with bladder cancer is olive 
oil. Both Goulas et al. [57] and Brinkman et al. [58] showed 
that a higher intake of olive oil reduced bladder cancer risk. 
Traditionally, it has been thought that the monounsaturated 
fat component of olive oil was at least partly responsible for 
the Mediterranean diet’s health benefits but, after reviewing 
our sensitivity analyses using different dietary fats, this does 
not appear to be the case.
A possible additional explanation for a protective effect 
of the Mediterranean diet might be the high concentration 
of polyphenols in olive oil. These dietary factors are well 
known for their anti-oxidative and anti-inflammatory prop-
erties [59, 60]. In addition, polyphenols have been shown to 
have a beneficial effect on cellular function [61]. Since pro-
cesses such as deregulated cell proliferation and suppressed 
cell death often provide a basis for tumour progression, 
polyphenols in olive oil may help to protect the cells of the 
bladder membrane against further metastasis [61]. High con-
centrations of polyphenols can also be found in wine, which 
is the main source of alcohol consumption in Mediterranean 
regions. Although it was expected that high concentrations 
of polyphenols from olive oil and wines could explain the 
beneficial effect of adhering to the Mediterranean diet on 
bladder cancer risk, it was not evident from our analyses. 
Therefore, more detailed analysis on polyphenols and other 
components of the Mediterranean diet in their relation to 
bladder cancer risk is needed to help explain the beneficial 
effect of high adherence.
Although BLEND is the largest known pooled cohort 
study investigating associations between adherence to the 
Mediterranean diet and risk of developing bladder cancer, 
with enough statistical power to permit detailed analyses 
and to detect smaller effects, it has several limitations. First, 
limited information was available for other possible risk fac-
tors for bladder cancer, such as body mass index, physical 
inactivity, socioeconomic status, and occupational exposures 
to carcinogenic chemicals. Adjustments for these factors 
could have influenced our results. Nevertheless, the current 
literature suggests only a small proportion of bladder cancer 
cases can be attributed to these factors [62–64]. The study 
of Buckland et al. [27] found a significantly inverse asso-
ciation for current smokers after stratification for smoking 
status. We repeated this stratified analysis using our data, 
and although the inverse association of a high adherence to 
the MDS and bladder cancer was only statistically signifi-
cant in ever smokers  (HRhigh 0.80, [95% CI 0.71, 0.89]), the 
stratified HR estimates did not seem to differ substantially 
between never smokers and ever smokers.
Another limitation of our study includes potential mis-
classification of frequency of food consumption derived 
from food frequency questionnaires (FFQs), which could 
lead to systematic and random error when estimating 
adherence to the Mediterranean diet within individual stud-
ies [65]. Also, we were not able to take into account any 
possible changes of dietary and lifestyle habits over time, 
which could lead to misclassification of long-term diet. 
As previously reported by Dugué et al. [28], using dietary 
scores does not overcome the limitations inherent to FFQs, 
but they may help to distinguish between individuals rather 
than using absolute amounts of specific foods. Lastly, most 
of the included cohort studies used self-reported question-
naires for the ascertainment of bladder cancer diagnosis. 
Previous research showed that gathering diagnostic cancer 
information by the use of self-reported questionnaires could 
lead to large amounts of false negative findings, that is, cases 
would be falsely classified as being a non-case [66]. This 
could have led to underestimation of the true association.
Conclusion
We found evidence that high adherence to the Mediterranean 
diet was associated with a reduced risk of developing blad-
der cancer. We could not isolate any particular subgroup 
of foods (e.g. fats, alcohol) from the MDS that provided a 
greater benefit over others. This may be because it describes 
the overall effect of the combined factors of the dietary pat-
tern to be most protective.
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